Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder

Biological Psychiatry

Volumn 56, Issue 2, 2004, Pages 129-134

  Chrapko, Wendy E ^a   Jurasz, Paul ^a   Radomski, Marek W ^a   Lara, Nathalie ^c   Archer, Stephen L ^a   Le Mellédo, Jean Michel ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c NONE

Author keywords

endothelium function; etiology; major depressive disorder; Nitric oxide; nitric oxide synthase; platelet

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; HISTORY OF MEDICINE; HUMAN; MAJOR DEPRESSION; MALE; MEDICAL EXAMINATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REDUCTION; SMOKING;

ADOLESCENT; ADULT; ANXIETY DISORDERS; BIOPTERIN; BLOOD PLATELETS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; REFERENCE VALUES;

EID: 3042609836     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.03.003     Document Type: Article

References (59)

1. Anderson T.J. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev. 8:2003;71-86
2. Archer S.L. Measurement of nitric oxide in biological models. FASEB J. 7:1993;349-360
3. Archer S.L., Djaballah K., Humbert M., Weir K.E., Fartoukh M., Dall'ava-Santucci J., et al. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. Am J Respir Crit Care Med. 158:1998;1061-1067
4. Bernstein H.-G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P., Bogerts B. Nitric oxide synthase-containing neurons in human hypothalamus Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience. 83:1998;867-875
5. Blair S.N., Haskell W.L., Ho P., Paffenbarger R.S. Jr, Vranizan K.W., Farquhar J.W., et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol. 122:1985;794-804
6. Cicinelli E., Ignarro L.J., Lograno M., Galantino P., Balzon G., Schonauer L.M. Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle. Fertil Steril. 6:1996;1036-1038
7. Faulx M.D., Wright A.T., Hoit B.D. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J. 145:2003;943-951
8. Feron O., Dessy C., Moniotte S Desager J.P., Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest. 6:1999;897-905
9. Freedman J.E., Loscalzo J., Barnard M.R., Alpert C., Keaney J.F., Michelson A.D. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 100:1997;350-356
10. Freedman J.E., Ting B., Hankin B., Loscalzo J., Keaney J.F., Vita J.A. Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation. 98:1998;1481-1486
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62
12. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., Nagatsu T. Plasma tetrahydrobiopterin levels in patients with psychiatric disorders. Neuropsychobiology. 23:1990;140-143
13. 298/Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 100:1999;1515-1520
14. Holven K.B., Holm T., Aukrust P., Christensen B., Kjeksus J., Andreasen A.K., et al. Effect of folic acid treatment on endothelium-dependent vasodilatation and nitric oxide-derived end products in hyoperhomocysteinemic subjects. Am J Med. 119:2001;536-542
15. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 65:1989;1-21
16. Jaffrey S.R., Snyder S.H. Nitric oxide A neural messenger. Annu Rev Cell Dev Biol. 11:1995;417-440
17. Joynt K.E., Whellan D.J., O'Connor C.M. Depression and cardiovascular disease Mechanisms of interaction. Biol Psychiatry. 54:2003;248-261
18. Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., Finkel M.S. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 42:1997;290-295
19. Landmesser U., Hornig B., Drexler H. Endothelial dysfunction in hypercholesterolemia Mechanisms, pathophysiology importance and therapeutic interventions. Semin Thromb Hemost. 26:2000;529-537
20. Lara N., Archer S.L., Baker G.B., Le Mellédo J.-M. Paroxetine-induced increase in metabolic end products of nitric oxide (NO). J Clin Psychopharm. 23:2003;641-645
21. Lederbogen F., Gilles M., Maras A., Hamann B., Colla M., Heuser I., Deuschle M. Increased platelet aggregability in major depression? Psychiatry Res. 102:2001;255-261
22. Le Mellédo J.-M., Baker G.B., Bailey D. Selective serotonin reuptake inhibitor and myocardial infarction. Circulation. 109:(3):2004;E19
23. Lespérance F., Frasure-Smith N., Talajic M., Bourassa M.G. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 105:2002;1049-1053
24. Maeda S., Miyauchi T., Kakiyama T., Sugawara J., Iemitsu M., Irukayama-Tomobe Y., et al. Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sci. 69:2001;1005-1016
25. Maher K.J., Mirzamohammadi B., Lteif A., Steinberg H.O., Baron A.D. Endothelium contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes. 51:2002;3517-3523
26. Mangos G.J., Walker B.R., Kelly J.J., Lawson J.A., Webb D.J., Whitworth J.A. Cortisol inhibits cholinergic vasodilatation in the human forearm. Am J Hypertens. 13:2000;1155-1160
27. Mehta J.L., Chen L.Y., Kone B.C., Mehta P., Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med. 125:1995;370-377
28. Moncada S., Higgs A. Mechanisms of disease The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012
29. Musselman D.L., Tomer A., Manatunga A.K., Knight B.T., Porter M.K., Kasey S., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 153:1996;1313-1317
30. Nemeroff C.B., Musselman D.L. Are platelets the link between depression and ischemic heart disease? Am Heart J. 140:2000;S57-S65
31. Node K., Kitakaze M., Yoshikawa H., Kosaka H., Hori M. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol. 79:1997;1538-1541
32. Node K., Kitakaze M., Yoshikawa H., Kosaka H., Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension. 30:1997;405-408
33. Perlmutter J.B., Frishman W.H., Feinstein R.E. Major depression as a risk factor for cardiovascular disease. Heart Dis. 2:2000;75-82
34. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenocortical axis. Psychiatr Clin North Am. 21:1998;293-307
35. Pratt L.A., Ford D.E., Crum R.A., Armenian H.K., Gallo J.J., Eaton W.W. Depression, psychotropic medication and risk of myocardial infarction Prospective data from the Baltimore ECA follow-up. Circulation. 94:1996;3123-3129
36. Radomski M., Moncada S. An improved method for washing of human platelets with prostacyclin. Thromb Res Suppl. 30:1983;383-389
37. Radomski M.W., Palmer R.M.J., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057-1058
38. Radomski M.W., Palmer R.M.J., Moncada S. The antiaggregating properties of vascular endothelium Interactions between prostacyclin and nitric oxide. Br J Pharmacol. 92:1987;639-646
39. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A. 87:1990;1788-1792
40. Radomski M.W., Vallance P., Whitley G., Foxwell N., Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res. 27:1993;1580-1582
41. Rajagopalan S., Brook R., Rubenfire M., Pitt E., Young E., Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol. 88:2001;196-198
42. Rapaport M.H. Prevalence, recognition and treatment of comorbid depression and anxiety. J Clin Psychiatry. 62:(suppl 24):2001;6-10
43. Rogers K.M., Bonar C.A., Estrella J.L., Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol. 27:2002;H1922-H1928
44. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 99:1999;2192-2217
45. Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., Kugiyama K., Ogawa H., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 31:1998;1506-1510
46. Shimokawa H. Primary dysfunction Atherosclerosis. J Mol Cell Cardiol. 31:1999;23-37
47. Suzuki E., Yagi G., Nakaki T., Kahba S., Asai M. Elevated plasma nitrate levels in depressive states. J Affect Dis. 63:2001;221-224
48. Szabo C (1998): Regulation of the expression of the inducible isoform of nitric oxide synthase by glucocorticoids. Ann N Y Acad Sci 851:336-341
49. Szabo C., Thiemermann C., Wu C.C., Peretti M., Vane J.R. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A. 91:1994;271-275
50. Tanaka S., Yashiro A., Nakashima Y., Nanri H., Ikeda M., Kuroiwa A. Plasma nitrite/nitrate level is inversely correlated with plasma low-density lipoprotein cholesterol level. Clin Cardiol. 20:1997;361-365
51. van Amsterdam J.G.C., Opperhuisen A. Nitric oxide and biopterin in depression and stress. Psychiatry Res. 85:1999;33-38
52. Vandivier R.W., Eidsath A., Banks S.M., Preas H.L. 2nd, Leighton S.B., Godin P.J., et al. Down-regulation of NO production by ibuprofen in human volunteers. J Pharmacol Exp Ther. 289:1999;1398-1402
53. Ventura J., Liberman R.P., Green M.F., Shaner A., Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res. 79:1998;163-173
54. Verna S., Buchanan M.R., Anderson T.J. Endothelial function testing as a biomarker of vascular disease. Circulation. 108:2003;2054-2059
55. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest. 56:1996;577-581
56. Wallerath T., Witte K., Schafer S.C., Schwartz P.M., Prellwitz W., Wohlfart P., et al. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A. 96:1999;13357-13362
57. Ware J.A., Heistad D.D. Platelet-endothelium interactions. N Engl J Med. 328:1993;628-635
58. White J.G. Platelets and atherosclerosis. Eur J Clin Invest. 24:(suppl 1):1994;25-29
59. Xing G., Chavko M., Zhang L.-X., Yang S., Post R.M. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res. 58:2002;21-30